<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345499</id>
  <title nil="true"/>
  <common-name>(2s,3s,5s,8s,9s,10s,13s,14s,16r,17s)-17-acetyl-3-hydroxy-10,13,16-trimethyl-2-morpholin-4-yl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one</common-name>
  <description>(2s,3s,5s,8s,9s,10s,13s,14s,16r,17s)-17-acetyl-3-hydroxy-10,13,16-trimethyl-2-morpholin-4-yl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one is a chemical compound with the formula C26H41NO4. It has an average molecular weight of 431.60 g/mol.</description>
  <cas>52-91-5</cas>
  <pubchem-id>120611</pubchem-id>
  <chemical-formula>C26H41NO4</chemical-formula>
  <weight>431.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:17:31Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:17:31Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1CC2C3CCC4CC(C(CC4(C3C(=O)CC2(C1C(=O)C)C)C)N5CCOCC5)O</moldb-smiles>
  <moldb-formula>C26H41NO4</moldb-formula>
  <moldb-inchi>InChI=1S/C26H41NO4/c1-15-11-19-18-6-5-17-12-21(29)20(27-7-9-31-10-8-27)13-25(17,3)24(18)22(30)14-26(19,4)23(15)16(2)28/h15,17-21,23-24,29H,5-14H2,1-4H3/t15-,17+,18+,19+,20+,21+,23-,24-,25+,26+/m1/s1</moldb-inchi>
  <moldb-inchikey>DSPCGJPMFCPSRR-YFZIMBFFSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">431.3035588</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341392</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(2s,3s,5s,8s,9s,10s,13s,14s,16r,17s)-17-acetyl-3-hydroxy-10,13,16-trimethyl-2-morpholin-4-yl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Lipids and lipid-like molecules</superklass>
  <klass>Steroids and steroid derivatives</klass>
  <subklass>Pregnane steroids</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0295856</sync-id>
  <structure-inchikey>DSPCGJPMFCPSRR-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>10000000000000000000000000000000000000000000002000000000020004000000000208000000000000010000000000000000000013080000000000080000000000200000020800001000000000000000000000000240000010000000000400000000000000000020108020000000000010000500000000048000000000000000000000000000004000000000000002000400020000800070004000008400000080800040008000040000000048000000000000000000000000100000000000000000000000000400000000000000000080000000000000000000002100000000000000400000000000000080000040000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAfAAAAIwAAAIABBgBgAAAAAQMGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:32Z</structure-indexed-at>
</compound>
